These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20607853)

  • 1. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
    Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
    Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.
    Lake A; Shield LA; Cordano P; Chui DT; Osborne J; Crae S; Wilson KS; Tosi S; Knight SJ; Gesk S; Siebert R; Hay RT; Jarrett RF
    Int J Cancer; 2009 Sep; 125(6):1334-42. PubMed ID: 19507254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.
    Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R
    Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
    Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
    J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
    Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
    Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
    Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
    J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma.
    Otto C; Giefing M; Massow A; Vater I; Gesk S; Schlesner M; Richter J; Klapper W; Hansmann ML; Siebert R; Küppers R
    Br J Haematol; 2012 Jun; 157(6):702-8. PubMed ID: 22469134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of Hodgkin lymphoma.
    Küppers R
    Hematology Am Soc Hematol Educ Program; 2009; ():491-6. PubMed ID: 20008234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation.
    Weniger MA; Melzner I; Menz CK; Wegener S; Bucur AJ; Dorsch K; Mattfeldt T; Barth TF; Möller P
    Oncogene; 2006 Apr; 25(18):2679-84. PubMed ID: 16532038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch and NF-κB signaling pathways in the biology of classical Hodgkin lymphoma.
    Schwarzer R; Jundt F
    Curr Mol Med; 2011 Apr; 11(3):236-45. PubMed ID: 21375490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity.
    Hinz M; Lemke P; Anagnostopoulos I; Hacker C; Krappmann D; Mathas S; Dörken B; Zenke M; Stein H; Scheidereit C
    J Exp Med; 2002 Sep; 196(5):605-17. PubMed ID: 12208876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.
    Steidl C; Diepstra A; Lee T; Chan FC; Farinha P; Tan K; Telenius A; Barclay L; Shah SP; Connors JM; van den Berg A; Gascoyne RD
    Blood; 2012 Oct; 120(17):3530-40. PubMed ID: 22955918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
    Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
    Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
    Lennerz JK; Hoffmann K; Bubolz AM; Lessel D; Welke C; Rüther N; Viardot A; Möller P
    Oncotarget; 2015 Oct; 6(30):29097-110. PubMed ID: 26336985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells.
    Emmerich F; Meiser M; Hummel M; Demel G; Foss HD; Jundt F; Mathas S; Krappmann D; Scheidereit C; Stein H; Dörken B
    Blood; 1999 Nov; 94(9):3129-34. PubMed ID: 10556199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines.
    Feys T; Poppe B; De Preter K; Van Roy N; Verhasselt B; De Paepe P; De Paepe A; Speleman F
    Haematologica; 2007 Jul; 92(7):913-20. PubMed ID: 17606441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.
    Barth TF; Martin-Subero JI; Joos S; Menz CK; Hasel C; Mechtersheimer G; Parwaresch RM; Lichter P; Siebert R; Möoller P
    Blood; 2003 May; 101(9):3681-6. PubMed ID: 12511414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation.
    Bose S; Starczynski J; Chukwuma M; Baumforth K; Wei W; Morgan S; Byrd P; Ying J; Grundy R; Mann JR; Tao Q; Taylor AM; Murray PG; Stankovic T
    J Pathol; 2007 Nov; 213(3):329-36. PubMed ID: 17876757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
    Krappmann D; Emmerich F; Kordes U; Scharschmidt E; Dörken B; Scheidereit C
    Oncogene; 1999 Jan; 18(4):943-53. PubMed ID: 10023670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.